Werner Jung

Villingen-schwenningen, BW, DE 
Villingen-schwenningen, BW, DE 

Overview

Werner Jung practices practicing medicine in Villingen-schwenningen, Germany.

His clinical expertise encompasses Stable Angina, Atrial Fibrillation, Coronary Heart Disease, Angioplasty, and Percutaneous Coronary Intervention (PCI).

He is actively involved in clinical research, co-authoring 47 peer reviewed articles and participating in 8 clinical trials.

Gender

Male

Locations

Villingen-schwenningen, BW, Germany
Other Locations
BioMonde GmbH
Barsbuettel, SH, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

REDUCER-I: An Observational Study of the Neovasc Reducer™ System
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
Enrollment Status: Active_not_recruiting
Publish Date: July 30, 2026
Intervention Type: Device
Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction
Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Device
Study Phase: Not Applicable
Nanostim Study for a Leadless Cardiac Pacemaker System
Nanostim Study for a Leadless Cardiac Pacemaker System
Enrollment Status: Completed
Publish Date: June 06, 2025
Intervention Type: Device
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: February 26, 2025
Intervention Type: Device
Study Phase: Not Applicable
Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry
Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry
Enrollment Status: Completed
Publish Date: July 19, 2022
German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
Enrollment Status: Completed
Publish Date: April 01, 2022
Intervention Type: Device
Practical Evaluation of Fractional Flow Reserve (FFR) and Its Associated Alternate Indices During Routine Clinical Procedures
Practical Evaluation of Fractional Flow Reserve (FFR) and Its Associated Alternate Indices During Routine Clinical Procedures
Enrollment Status: Completed
Publish Date: February 07, 2020
Intervention Type: Device
Prospective, Multi-centre, Randomized, Parallel Comparison to Evaluate the Safety and Efficacy of the Abluminal Sirolimus Coated Bio-engineered Stent (COMBO Stent) in Association With Short-term Single Antiplatelet Therapy in Patients With Coronary Artery Disease With an Indication for Chronic Oral Anticoagulant Therapy as Compared to a Guidelines-based Strategy
Prospective, Multi-centre, Randomized, Parallel Comparison to Evaluate the Safety and Efficacy of the Abluminal Sirolimus Coated Bio-engineered Stent (COMBO Stent) in Association With Short-term Single Antiplatelet Therapy in Patients With Coronary Artery Disease With an Indication for Chronic Oral Anticoagulant Therapy as Compared to a Guidelines-based Strategy
Enrollment Status: Withdrawn
Publish Date: February 20, 2017
Intervention Type: Device, Drug
Study Phase: Phase 4
View 7 Less Clinical Trials

47 Total Publications

Cardiovascular Magnetic Resonance to Guide Defibrillator Implantation for LVEF of 36% to 50%: The CMR GUIDE Randomized Clinical Trial.
Cardiovascular Magnetic Resonance to Guide Defibrillator Implantation for LVEF of 36% to 50%: The CMR GUIDE Randomized Clinical Trial.
Journal: JAMA
Published: August 28, 2026

Frequently Asked Questions about Werner Jung

Is Werner Jung a top-rated expert for Stable Angina?

MediFind is an objective health platform that identifies experts based on real-world data. Werner Jung is classified as an Experienced expert for Stable Angina, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Werner Jung participate in research or clinical trials?

Yes. Werner Jung has published 47 articles and abstracts on conditions like Stable Angina. You can view a list of Werner Jung's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Jung's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile